139 related articles for article (PubMed ID: 7882484)
1. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study.
Barrett-Connor E; Goodman-Gruen D
Circulation; 1995 Mar; 91(6):1757-60. PubMed ID: 7882484
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of DHEAS and cardiovascular disease.
Barrett-Connor E; Goodman-Gruen D
Ann N Y Acad Sci; 1995 Dec; 774():259-70. PubMed ID: 8597464
[TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.
Khaw KT
J Endocrinol; 1996 Sep; 150 Suppl():S149-53. PubMed ID: 8943798
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.
Barrett-Connor E; Khaw KT; Yen SS
N Engl J Med; 1986 Dec; 315(24):1519-24. PubMed ID: 2946952
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study.
Barrett-Connor E; Ferrara A
J Clin Endocrinol Metab; 1996 Jan; 81(1):59-64. PubMed ID: 8550794
[TBL] [Abstract][Full Text] [Related]
6. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study.
Johannes CB; Stellato RK; Feldman HA; Longcope C; McKinlay JB
J Clin Epidemiol; 1999 Feb; 52(2):95-103. PubMed ID: 10201649
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bernardo Study.
Barrett-Connor E; Edelstein SL
J Am Geriatr Soc; 1994 Apr; 42(4):420-3. PubMed ID: 8144828
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women.
Barrett-Connor E; Kritz-Silverstein D; Edelstein SL
Am J Epidemiol; 1993 Jan; 137(2):201-6. PubMed ID: 8452124
[TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men.
LaCroix AZ; Yano K; Reed DM
Circulation; 1992 Nov; 86(5):1529-35. PubMed ID: 1423966
[TBL] [Abstract][Full Text] [Related]
10. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study.
Laughlin GA; Barrett-Connor E; Criqui MH; Kritz-Silverstein D
J Clin Endocrinol Metab; 2004 Jan; 89(1):114-20. PubMed ID: 14715837
[TBL] [Abstract][Full Text] [Related]
11. Dehydroepiandrosterone sulfate and breast cancer risk.
Barrett-Connor E; Friedlander NJ; Khaw KT
Cancer Res; 1990 Oct; 50(20):6571-4. PubMed ID: 2145063
[TBL] [Abstract][Full Text] [Related]
12. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study.
Park S; Barrett-Connor E; Wingard DL; Shan J; Edelstein S
Diabetes Care; 1996 May; 19(5):450-6. PubMed ID: 8732708
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of sex hormone-binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women.
Goodman-Gruen D; Barrett-Connor E
J Clin Endocrinol Metab; 1996 Aug; 81(8):2999-3003. PubMed ID: 8768865
[TBL] [Abstract][Full Text] [Related]
14. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
15. Sex and time differences in the associations of non-high-density lipoprotein cholesterol versus other lipid and lipoprotein factors in the prediction of cardiovascular death (The Rancho Bernardo Study).
von Mühlen D; Langer RD; Barrett-Connor E
Am J Cardiol; 2003 Jun; 91(11):1311-5. PubMed ID: 12767422
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: the Rancho Bernardo Study.
Tannenbaum C; Barrett-Connor E; Laughlin GA; Platt RW
Eur J Endocrinol; 2004 Dec; 151(6):717-25. PubMed ID: 15588238
[TBL] [Abstract][Full Text] [Related]
17. Relationship of body fat percentage and fat distribution with dehydroepiandrosterone sulfate in premenopausal females.
Williams DP; Boyden TW; Pamenter RW; Lohman TG; Going SB
J Clin Endocrinol Metab; 1993 Jul; 77(1):80-5. PubMed ID: 8325963
[TBL] [Abstract][Full Text] [Related]
18. Type A behavior pattern, heart disease risk factors, and estrogen replacement therapy in postmenopausal women: the Rancho Bernardo Study.
Buller JC; Kritz-Silverstein D; Barrett-Connor E; Wingard D
J Womens Health; 1998 Feb; 7(1):49-56. PubMed ID: 9511132
[TBL] [Abstract][Full Text] [Related]
19. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study.
Feldman HA; Johannes CB; Araujo AB; Mohr BA; Longcope C; McKinlay JB
Am J Epidemiol; 2001 Jan; 153(1):79-89. PubMed ID: 11159150
[TBL] [Abstract][Full Text] [Related]
20. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
